Molecular Characterization of Whole-Genome SARS-CoV-2 from the First Suspected Cases of the XE Variant in the Lazio Region, Italy.

COVID-19 Nextclade PANGOLIN SARS-CoV-2 XE recombination whole-genome sequencing

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
14 Sep 2022
Historique:
received: 10 08 2022
revised: 02 09 2022
accepted: 10 09 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

We report two cases of SARS-CoV-2 recombinant variant XE detected in nasopharyngeal swabs (NPS) of hospitalized patients with no evident epidemiological link in Lazio, Central Italy. Whole-Genome Sequencing (WGS) performed on an Ion Torrent GSS5 platform according to Italian flash surveys showed genomes corresponding to the PANGOLIN unclassified lineage and the Nextclade XE clade. Further analyses were then carried out to investigate more deeply the genetic characteristics of these XE-like sequences. When phylogenetic trees, by using IQ-TREE, were built splitting the genome into two regions according to the putative XE recombination site, the upstream and downstream regions were seen to be clustered near BA.1 and BA.2 sequences, respectively. However, our XE-like sequences clustered separately, with a significant bootstrap, from the classified European and Italian XE strains, although the recombination site between BA.1 and BA.2 was identified at the nucleotide site 11556 by RDP4 software, consistent with the putative XE breakpoint. These findings show the risk of the introduction of novel recombinant variants of SARS-CoV-2 and the existence of XE-like strains, phylogenetically separated, that could make their exact taxonomy difficult. It follows the need for continued SARS-CoV-2 surveillance by WGS.

Identifiants

pubmed: 36140622
pii: diagnostics12092219
doi: 10.3390/diagnostics12092219
pmc: PMC9497488
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : Ricerca Corrente - linea 1
Organisme : Ministero della Salute
ID : 5M-2020-23682104
Organisme : European Commission
ID : 101003544 - CoNVat
Organisme : European Commission
ID : 101005075-KRONO
Organisme : European Virus Archive - GLOBAL
ID : 871029

Références

Front Microbiol. 2022 May 18;13:870759
pubmed: 35663855
Cell. 2021 Sep 30;184(20):5179-5188.e8
pubmed: 34499854
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Genome Biol Evol. 2022 Feb 4;14(2):
pubmed: 35137080
Nat Rev Microbiol. 2011 Jul 04;9(8):617-26
pubmed: 21725337
J Med Virol. 2022 Oct;94(10):4628-4643
pubmed: 35705439
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
J Gen Virol. 2018 Oct;99(10):1345-1356
pubmed: 30156526
Mol Biol Evol. 2021 Jun 25;38(7):3022-3027
pubmed: 33892491
Sci Rep. 2021 Aug 30;11(1):17365
pubmed: 34462471
J Clin Virol Plus. 2022 Aug;2(3):100084
pubmed: 35620035
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
Science. 2021 Aug 27;373(6558):968-970
pubmed: 34404734
Viruses. 2022 Feb 25;14(3):
pubmed: 35336879
Euro Surveill. 2022 Feb;27(5):
pubmed: 35115077
J Transl Med. 2021 Jun 5;19(1):246
pubmed: 34090468
J Virol. 2022 Mar 23;96(6):e0207721
pubmed: 35225672
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Infect Genet Evol. 2015 Mar;30:296-307
pubmed: 25541518
China CDC Wkly. 2021 Dec 3;3(49):1049-1051
pubmed: 34934514
Virus Evol. 2015 May 26;1(1):vev003
pubmed: 27774277
JMIR Bioinform Biotech. 2022 Mar 14;3(1):e31536
pubmed: 35309411
Int J Biol Macromol. 2021 May 15;179:1-19
pubmed: 33667553
Int J Biol Macromol. 2022 May 31;208:105-125
pubmed: 35300999
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Cell Rep. 2022 Jun 28;39(13):111009
pubmed: 35732171
Int J Surg. 2022 Jun;102:106670
pubmed: 35569759
Viruses. 2022 Jun 07;14(6):
pubmed: 35746710
Epidemiol Infect. 2021 Nov 04;149:e237
pubmed: 34732275

Auteurs

Martina Rueca (M)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Emanuela Giombini (E)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Giulia Gramigna (G)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Cesare Ernesto Maria Gruber (CEM)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Lavinia Fabeni (L)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Angela Corpolongo (A)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Valentina Mazzotta (V)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Luisella Corso (L)

Department Clinical Pathology, S.M. Goretti Hospital, 04100 Latina, Italy.

Ornella Butera (O)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Maria Beatrice Valli (MB)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Fabrizio Carletti (F)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Stefano Pignalosa (S)

Department Clinical Pathology, S.M. Goretti Hospital, 04100 Latina, Italy.

Francesco Vairo (F)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Emanuele Nicastri (E)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Andrea Antinori (A)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Enrico Girardi (E)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Francesco Vaia (F)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Fabrizio Maggi (F)

National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.

Classifications MeSH